These data indicate that telomestatin potently eradicates GSCs through telomere disruption and c-Myb inhibition, and this study suggests a novel GSC-directed therapeutic strategy for GBMs.
Clinical cancer research : an official journal of the American Association for Cancer Research
Department of Neurological Surgery, Dardinger, Center for Neuro-oncology, James Cancer Hospital and The Ohio State University, Columbus, Ohio 43210, USA.
Clin Cancer Res. 2012 Mar;18(5):1268-80
© Galenicom 1999-2013